United States:
Healthcare & Life Sciences Private Equity Deal Tracker: OrthoSensor Secures $19 Million In Financing
01 April 2015
McGuireWoods LLP
To print this article, all you need is to be registered or login on Mondaq.com.
OrthoSensor
has announced it has raised $19 million in a private placement
of series C preferred stock.
OrthoSensor, based in Dania
Beach, FL, is a developer of intelligent orthopedic devices and
data services.
Participating in the financing round were Bridger Healthcare and
The Tullis Growth Fund.
OrthoSensor indicated the funding would be used to support the
commercialization of VERASENSE, the company's disposable,
sensor-assisted, total knee replacement device, as well as to
expand product development.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...